title: 18F-FDG PET/CT of transitional cell carcinoma.
abstract: OBJECTIVE
  The objective of this article is to provide a practical illustrated review of PET/CT in the imaging evaluation of transitional cell carcinoma.
  
  
  CONCLUSIONS
  Local evaluation of the primary tumor in patients with transitional cell carcinoma on PET is often limited by the obscuring effect of excreted FDG, but assessment of metabolic activity may still be possible through close correlation with CT images. PET/CT may also be helpful in the detection of disease outside the bladder at nodal or more distant sites and in the assessment of recurrent disease.
authors.affiliation: Department of Radiology, University of California San Francisco, San Francisco, CA 94143-0628, USA.
authors.forename: Vivek V
authors.initials: VV
authors.lastname: Patil
authors.forename: Zhen J
authors.initials: ZJ
authors.lastname: Wang
authors.forename: Richard A
authors.initials: RA
authors.lastname: Sollitto
authors.forename: Kai-Wen
authors.initials: KW
authors.lastname: Chuang
authors.forename: Badrinath R
authors.initials: BR
authors.lastname: Konety
authors.forename: Randy A
authors.initials: RA
authors.lastname: Hawkins
authors.forename: Fergus V
authors.initials: FV
authors.lastname: Coakley
mesh_terms: D002295:Carcinoma, Transitional Cell / Q000000981:diagnostic imaging* / Q000473:pathology; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging / Q000473:pathology; D009367:Neoplasm Staging / Q000379:methods; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed / Q000379:methods*; D001749:Urinary Bladder Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18